A series of random questions answered by Harvard experts.
Campus debate weighs therapeutic need vs. safety questions
Findings suggest colibactin may be promising target for disease prevention
Michael VanRooyen started running toward trouble more than 30 years ago. He’s still going.
New research suggests that it disrupts biological clock
5 min read
Complexity of finance system sets up many for failure, argues economics professor
7 min read
Forget influencers, nutritionist says. Here’s how much you really need, why too much can actually hurt you
8 min read